In a study on people with obesity and asthma, researchers saw “significant” improvements in the asthma scores of people who ...

Weight-loss jabs such as Mounjaro could also help minimise asthma symptoms in obese people, says a new study, as the NHS ...

Weight-loss jabs could help minimise asthma symptoms in obese people, according to a study. The drugs should be explored as a ...

The primary efficacy outcome among the 550 participants with initially uncontrolled asthma showed significantly better ...

A digital asthma self-management program enhanced symptom control; however, it revealed racial disparities in engagement, highlighting the need for culturally tailored interventions.

GLP1 agonist drugs, commonly known by brand names such as Ozempic and Mounjaro, reduce asthma symptoms in obese people ...

A mobile asthma self-management tool improved symptoms in adults with uncontrolled asthma, but its effectiveness varied ...

Stepping down to as-needed ICS/FABA maintained asthma stability while significantly reducing steroid exposure in individuals ...

Weight loss injections could help to reduce asthma symptoms in obese people, according to researchers at the University of ...

Among patients with severe asthma receiving dupilumab for 12 months, 91% had a clinical response and 30% achieved clinical remission.

A groundbreaking clinical trial led by multidisciplinary researchers found that a digital asthma self-management (DASM) program significantly improved asthma symptom control in adults, with benefits ...

New research suggests that expectations are associated with asthma outcomes. People who thought more negatively about their ...